Company Overview and News

1
A Year Of Stock Recommendations On Seeking Alpha

6h seekingalpha
Today I wanted to take the time to review the recommendations that I made, how they have performed, and whether I would still recommend purchasing at current prices.

2
John's April Dividend Income Tracker - Retirement Accounts

2018-05-21 seekingalpha
This is the second month I have officially tracked dividend income (in an article) for John's Traditional and Roth IRA Accounts. His combined dividend income totaled $1789.12.

 
Look Here for Safe High-Yield Investments and Guaranteed Returns

2018-05-21 investorplace
When volatility picks up, investors flock to safety. It’s not a recent investment thesis or one derived from algorithmic trading. It’s a long-time reaction that’s generally driven by human psychology. As fears rise, investors first seek cash and then look for safe high-yield investments.

 
Young And In REITs: An Introduction To My Portfolio And Me

2018-05-21 seekingalpha
In this article I explain my investing strategy and provide 100% access to my real-money portfolio.

 
7.92% Preferred Share Best Option By Far

2018-05-20 seekingalpha
Investors focused on the common stock should look elsewhere. We are only talking about the preferred shares today.

 
High-Quality REIT Yielding 6% Is Off To A Strong Start, 35% Upside Potential

2018-05-19 seekingalpha
Ventas is one of our strongest picks among REITs because it is what we consider to be a blue-chip company with a low risk profile.

 
Retirement Security: How To Navigate Market Volatility

2018-05-19 seekingalpha
Has the return of volatility the last three months have you wondering how best to deal with it?

 
Realty Income's Hiatus On Issuing New Shares

2018-05-18 seekingalpha
Realty Income Issued over 32 million shares in 2016 and 2017 at an average price of more than $59 per share.

 
Macro Trumps Micro - Part I: Equity REITs That Even Fortune Tellers Hold

2018-05-17 seekingalpha
1. It was around mid-2016 when I turned bearish on many equity REITs (VNQ, IYR, RWR, ICF, SCHH, XLRE) At the time, most readers thought that I was wrong and I became known as one of SA's most anti-eREITs contributors.

 
Jane's April Dividend Income Tracker - Retirement Accounts

2018-05-15 seekingalpha
This is the second month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her combined dividend income totaled $1,300.03.

 
W.P. Carey Still An Excellent Dividend Payer

2018-05-15 seekingalpha
WPC is a leader in the triple net lease sector and pays a very nice dividend too.

 
Too Good To Be True?

2018-05-14 seekingalpha
I was simply pursuing a hobby, and little did I know that I would become the top writer on Seeking Alpha (based on annual clicks).

 
DGI For The DIY: Q1 2018 Portfolio Update

2018-05-13 seekingalpha
A busy home schedule has limited my time dedicated to the stock market, but my dividend growth portfolio continues to perform without me.

3
Joseph To Pharaoh: Save Surplus Grain For Inevitable Droughts And Famine

2018-05-12 seekingalpha
More than that, investing your surplus in stalwarts like AT&T will see you through both the droughts and famines.

 
7 Stocks Paying Monthly Dividends That You Should Consider Buying

2018-05-12 investorplace
Nowadays, it seems like a lot of stocks want to become monthly dividend stocks. The granddaddy of monthly dividend stocks is Realty Income Corp (NYSE:O). In fact, it even has a registered trademark: “The Monthly Dividend Company”.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...